TITLE

METFORMIN FOR WEIGHT LOSS

PUB. DATE
September 2004
SOURCE
Life Extension;Sep2004, Vol. 10 Issue 9, p32
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Points out that while metformin is used to treat diabetes, published research shows that it also helps non-diabetics to lose weight. Ability of metformin to reduce sugar release from liver to prevent blood glucose levels from rising too high, so that the body does not need to produce as much insulin; Ability of metformin to prevent many of the side effects of diabetes.
ACCESSION #
14089086

 

Related Articles

  • Options for treating obesity. Campbell, Ian // GP: General Practitioner;4/26/2002, p70 

    Focuses on the options for general practitioners in treating obesity. Effectiveness of anti-obesity drugs; Requirements for drug administration; Importance of setting realistic targets.

  • Long-Term Results of Drug Treatment for Obesity. SLAWSON, DAVID // American Family Physician;3/1/2014, Vol. 89 Issue 5, p389 

    The article presents answers to a question on whether weight loss medications are effective as long-term treatment for obesity.

  • 5 that work. Nachatelo, Melissa // Natural Health;May/Jun2001, Vol. 31 Issue 4, p70 

    Presents information about different natural diet supplements used in the management of obesity. Green tea; Ephedra; Chromium.

  • New experimental drug helps obese patients lose weight.  // New York Amsterdam News;02/25/99, Vol. 90 Issue 9, p14 

    Highlights the results of a study conducted at Baylor College of Medicine in Houston, Texas indicating the potency of orlistat to promote weight loss among obese patients. Need for the combination of moderate-calorie diet; Mechanism of the drug's action; Adverse reactions.

  • The Role of Anti-obesity Drugs in Patients with Type 2 Diabetes. Hollander, Priscilla // U.S. Endocrinology;Winter2013, Vol. 9 Issue 2, p101 

    The prevalence of diabetes continues to rise, following the rising rates of obesity. Obesity is not only associated with an increased risk for developing type 2 diabetes but also an elevated probability of developing long-term complications associated with the disease. Weight gain is also an...

  • Your Insulin Therapy.  // American Family Physician;8/1/2004, Vol. 70 Issue 3, p511 

    Presents information on insulin therapy. Kinds of insulin; Symptoms of low blood sugar; Mealtime insulin type and dose.

  • Dia-B Tech: ISF402 progress promising but slow.  // PharmaWatch: Monthly Review;Mar2005, Vol. 4 Issue 3, p23 

    The article presents a study conducted by Monash University, which identifies that the newly invented drug ISF402 could help type 2 diabetes sufferers lower blood glucose levels and enhance the effects of insulin in the U.S. The major advantage of the drug over existing therapies is that ISF is...

  • Insulet: omnipresent treatment.  // PharmaWatch: Monthly Review;Mar2005, Vol. 4 Issue 3, p23 

    The article reports that Insulet Corp. has launch its first commercial product, the OmniPod Insulin Management System in the U.S. It has already received commercial clearance from the Food and Drug Administration. The two-part system will combine the healthcare benefits of continuous...

  • Cdk5-dependent regulation of glucose-stimulated insulin secretion. Fan-Yan Wei; Nagashima, Kazuaki; Ohshima, Toshio; Saheki, Yasunori; Yun-Fei Lu; Matsushita, Masayuki; Yamada, Yuichiro; Mikoshiba, Katsuhiko; Seino, Yutaka; Matsui, Hideki; Tomizawa, Kazuhito // Nature Medicine;Oct2005, Vol. 11 Issue 10, p1104 

    Tight glycemic control in individuals with diabetes mellitus is essential to prevent or delay its complications. Present treatments to reduce hyperglycemia mainly target the ATP-sensitive K+ (KATP) channel of pancreatic beta cells to increase insulin secretion. These current approaches are often...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics